Comparison of the OptiMAL rapid antigen test with field microscopy for the detection of Plasmodium vivax and P. falciparum: considerations for the application of the rapid test in Afghanistan.
To establish the sensitivity and specificity of a batch of 'OptiMAL 48' rapid antigen tests procured by the World Health Organization in Afghanistan, a sample was tested, in parallel with routine, microscopical diagnosis, at basic health units (BHU) within Afghan refugee camps in Pakistan. The results of both methods of field diagnosis were compared with those of cross-checking microscopy at a reference laboratory, which were taken as the 'gold standard'. Out of 499 patients examined, 36% were diagnosed as malaria cases by field microscopy and 34% by the rapid test. For the OptiMAL 48 test, cross-checking of the corresponding smears at the reference laboratory gave a sensitivity of 79.3% and a specificity of 99.7% for Plasmodium falciparum and corresponding values of 86.1% and 98.7% for P. vivax infections. The performance of the field microscopy was better, with a sensitivity and specificity of 85.2% and 99.7% for P. falciparum, and 90.4% and 98.7% for P. vivax, respectively. These results show that the performance of OptiMAL 48 is adequate for acute- and post-emergency situations when the alternative is just clinical diagnosis. However, in the developing health system of Afghanistan, the main focus should be on the expansion of the existing network for microscopical diagnosis and quality control, to meet the needs of a stable situation. Rapid antigen tests are more suited to investigations of outbreaks in remote situations, where health services are deficient or absent.
Kolaczinski
J
J
Health Net International, 11-A Circular Lane, PO Box 889, University Town, Peshawar, Pakistan. jan.kolaczinski@lshtm.ac.uk
Mohammed
N
N
Ali
I
I
Ali
M
M
Khan
N
N
Ezard
N
N
Rowland
M
M
D000346:Afghanistan / Q000453:epidemiology; D000953:Antigens, Protozoan / Q000032:analysis*; D003951:Diagnostic Errors; D019353:Endemic Diseases; D006801:Humans; D007159:Immunologic Tests / Q000379:methods; D008288:Malaria / Q000175:diagnosis* / Q000453:epidemiology / Q000276:immunology; D016778:Malaria, Falciparum / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology; D016780:Malaria, Vivax / Q000175:diagnosis / Q000453:epidemiology / Q000276:immunology; D008853:Microscopy / Q000379:methods; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity
D000953:Antigens, Protozoan; D011933:Reagent Kits, Diagnostic